Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

In a Different Vein: News From the Blood Journals Portfolio

Recent research from ASH’s Blood journals

For articles on research from Blood and Blood Advances published prior to May 2024, visit Written in Blood and Blood Advances in a Different Vein.

SACRED Trial Shows Utility of Hydroxyurea for Stroke Prevention in Hispanic Children with SCA
Ruth Jessen Hickman, MD
March 20, 2025
BCMA CAR T Cells Effective, Safe for Older Adults and Frail Patients with R/R Multiple Myeloma
Lara C. Pullen, PhD
March 12, 2025
Mass Spectrometry an Effective Method to Detect Measurable Residual Disease in Multiple Myeloma
Anna Azvolinsky, PhD
February 26, 2025
Odronextamab Monotherapy Appears Safe, Effective in R/R DLBCL With Progression After CAR-T
Katie Robinson
February 26, 2025
Elderly Patients With BPDCN Respond Well to Venetoclax, Bortezomib, Dexamethasone Combination
Lara C. Pullen, PhD
February 26, 2025
Azacitidine Plus Venetoclax May Offer Path to HCT for Patients with High-Risk Treatment-Naïve Myelodysplastic Syndromes
Khylia Marshall
February 26, 2025
Telemedicine Approach Helps Improve IC-Based SCD Pain Management
Thomas R. Collins
February 26, 2025
Relapse-Free Survival Progressively Shortens in Black Patients With Rituximab-Treated iTTP
Katie Robinson
January 30, 2025
Danicopan Plus Ravulizumab, Eculizumab Shows Long-Term Efficacy in PNH With Clinically Significant EVH
Katie Robinson
January 30, 2025
Combination of Venetoclax, Lower Intensity CPX-351 Shows Positive Results in Early-Stage AML Study
Anna Azvolinsky, PhD
January 30, 2025
EMD Lesions Comprise Multicellular Ecosystems With New Therapeutic Avenues
Katie Robinson
January 29, 2025
Anxiety, Depression Elevated in Patients with Histiocytic Neoplasms
Lara C. Pullen, PhD
January 25, 2025
Daratumumab Plus Lenalidomide Combination Improves Conversion to MRD-Negative Status in Post-Transplant Patients With Multiple Myeloma
Anna Azvolinsky, PhD
December 18, 2024
ASH Recruitment Program Boosts Representation in Hematology Field, Study Shows
Anna Azvolinsky, PhD
December 13, 2024
BOVen Regimen NCCN-Approved Option for TP53-Mutated MCL
Leah Lawrence
December 13, 2024
Weekly Low-Dose Regimen of Decitabine and Venetoclax as Effective as Higher Dose
Lara C. Pullen, PhD
December 13, 2024
Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Respond Well to Asciminib, Dasatinib
Lara C. Pullen, PhD
November 22, 2024
Soluble Anti-B-Cell Maturation Antigen, High Disease Burden Modulate Responses in Patients With MM Receiving BCMA T-Cell–Engager Therapy
Lara C. Pullen, PhD
November 21, 2024
Experts Release Guidance on Liver-Related Toxicities With Gene Therapy for Hemophilia A
Anna Azvolinsky, PhD
November 14, 2024
Venetoclax Effective for Bridging to Transplant in R/R AML, Study Suggests
Thomas R. Collins
November 14, 2024

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
March 2025

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals